A detailed history of Northern Oak Wealth Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Northern Oak Wealth Management Inc holds 173,911 shares of BMY stock, worth $10.2 Million. This represents 1.05% of its overall portfolio holdings.

Number of Shares
173,911
Previous 175,433 0.87%
Holding current value
$10.2 Million
Previous $7.29 Million 23.53%
% of portfolio
1.05%
Previous 0.88%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$39.66 - $51.75 $60,362 - $78,763
-1,522 Reduced 0.87%
173,911 $9 Million
Q2 2024

Jul 26, 2024

BUY
$40.25 - $52.99 $223,105 - $293,723
5,543 Added 3.26%
175,433 $7.29 Million
Q1 2024

May 01, 2024

BUY
$47.98 - $54.4 $1.65 Million - $1.87 Million
34,336 Added 25.33%
169,890 $9.21 Million
Q4 2023

Jan 11, 2024

SELL
$48.48 - $57.85 $323,943 - $386,553
-6,682 Reduced 4.7%
135,554 $6.96 Million
Q3 2023

Oct 24, 2023

SELL
$57.89 - $64.73 $4,110 - $4,595
-71 Reduced 0.05%
142,236 $8.26 Million
Q2 2023

Jul 31, 2023

BUY
$63.71 - $70.74 $1.84 Million - $2.04 Million
28,843 Added 25.42%
142,307 $9.1 Million
Q1 2023

May 09, 2023

BUY
$65.71 - $74.53 $351,285 - $398,437
5,346 Added 4.94%
113,464 $7.86 Million
Q4 2022

Feb 13, 2023

SELL
$68.48 - $81.09 $288,848 - $342,037
-4,218 Reduced 3.75%
108,118 $7.78 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $91 - $53,864
-701 Reduced 0.62%
112,336 $7.99 Million
Q2 2022

Aug 16, 2022

SELL
$72.62 - $79.98 $4.93 Million - $5.43 Million
-67,853 Reduced 37.51%
113,037 $8.7 Million
Q1 2022

May 24, 2022

SELL
$61.48 - $73.72 $2.07 Million - $2.48 Million
-33,636 Reduced 15.68%
180,890 $13.2 Million
Q4 2021

Feb 16, 2022

BUY
$53.63 - $62.52 $116,645 - $135,981
2,175 Added 1.02%
214,526 $13.4 Million
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $292,891 - $343,084
4,950 Added 2.39%
212,351 $12.6 Million
Q2 2021

Aug 17, 2021

BUY
$61.91 - $67.42 $336,047 - $365,955
5,428 Added 2.69%
207,401 $13.9 Million
Q1 2021

May 14, 2021

SELL
$59.34 - $66.74 $354,378 - $398,571
-5,972 Reduced 2.87%
201,973 $12.8 Million
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $326,404 - $369,875
5,653 Added 2.79%
207,945 $12.9 Million
Q3 2020

Nov 16, 2020

BUY
$57.43 - $63.64 $803,905 - $890,832
13,998 Added 7.43%
202,292 $12.2 Million
Q2 2020

Aug 17, 2020

BUY
$54.82 - $64.09 $3.93 Million - $4.6 Million
71,746 Added 61.56%
188,294 $11.1 Million
Q1 2020

May 15, 2020

SELL
$46.4 - $67.43 $2.6 Million - $3.78 Million
-56,034 Reduced 32.47%
116,548 $6.5 Million
Q4 2019

Jan 27, 2020

SELL
$49.21 - $64.19 $1.02 Million - $1.33 Million
-20,723 Reduced 10.72%
172,582 $11.1 Million
Q3 2019

Oct 31, 2019

BUY
$42.77 - $50.71 $7.54 Million - $8.94 Million
176,297 Added 1036.55%
193,305 $9.8 Million
Q2 2019

Jul 30, 2019

BUY
$44.62 - $49.34 $62,958 - $69,618
1,411 Added 9.05%
17,008 $0
Q1 2019

Apr 24, 2019

SELL
$45.12 - $53.8 $67,183 - $80,108
-1,489 Reduced 8.71%
15,597 $0
Q4 2018

Feb 14, 2019

SELL
$48.76 - $63.23 $95,862 - $124,310
-1,966 Reduced 10.32%
17,086 $888,000
Q3 2018

Nov 15, 2018

SELL
$55.19 - $62.25 $38,357 - $43,263
-695 Reduced 3.52%
19,052 $0
Q2 2018

Aug 13, 2018

SELL
$50.53 - $62.98 $6.65 Million - $8.29 Million
-131,601 Reduced 86.95%
19,747 $0
Q1 2018

May 11, 2018

BUY
$59.92 - $68.98 $117,622 - $135,407
1,963 Added 1.31%
151,348 $0
Q4 2017

Feb 16, 2018

BUY
$59.94 - $65.35 $638,480 - $696,108
10,652 Added 7.68%
149,385 $0
Q3 2017

Nov 15, 2017

BUY
$55.23 - $63.74 $7.66 Million - $8.84 Million
138,733
138,733 $0

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Northern Oak Wealth Management Inc Portfolio

Follow Northern Oak Wealth Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Oak Wealth Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Northern Oak Wealth Management Inc with notifications on news.